Dyne therapeutics insider trading
WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. ... In other news, insider Jonathan Mcneill sold 10,000 shares of the company’s stock in a transaction on … WebMar 25, 2024 · Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) shares traded down 3.1% during mid-day trading on Thursday . The stock traded as low as $11.12 and last traded at $11.12. 61,850 shares were traded during mid-day trading, a decline of 80% from the average session volume of 312,995 shares. The stock had previously closed at …
Dyne therapeutics insider trading
Did you know?
WebApr 11, 2024 · Somero Enterprises Trading Up 0.1 % The firm’s 50-day simple moving average is GBX 390.94 and its 200 day simple moving average is GBX 393.24. The stock has a market cap of £202.75 million, a P ... WebMar 15, 2024 · In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of $1.64B and bought an estimated value of $64.19M worth of shares. Insider trading is most common in March ...
WebApr 11, 2024 · Athabasca Oil Co. (TSE:ATH – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$2.65 and traded as high as ... WebMar 14, 2024 · Dyne Therapeutics, Inc. Stock Insider Trading. Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 41.593. In total, the insiders bought 3 463 242 and sold 1 329 813 DYN shares in the last 100 trades.
WebDYN : 11.52 (-0.52%) Wall Street Analysts Predict a 141% Upside in Dyne Therapeutics, Inc. (DYN): Here's What You Should Know Zacks - Wed Nov 30, 2024. The mean of analysts' price targets for Dyne Therapeutics, Inc. (DYN) points to a 141% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... WebApr 3, 2024 · Source. Headline. Dyne Therapeutics (NASDAQ:DYN) Trading Down 3.1%. americanbankingnews.com - March 25 at 7:38 AM. Dyne Therapeutics Announces Orphan Drug And Rare Pediatric Designations For DYNE-251. markets.businessinsider.com - March 23 at 2:04 PM. Dyne Gets FDA Orphan, Rare-Pediatric-Disease Designations for DYNE …
WebDyne Therapeutics Inc. DYN: Beskrovnaya Oxana Chief Scientific Officer: 712: $14.05: 52,238 (Direct) View: 2024-07-11 Option Award: 2024-07-13 4:38 pm: N/A 2032-07-10: …
list of directors and shareholdersWebApr 13, 2024 · Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the ... list of directors in mcaWebDYN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Dyne Therapeutics Inc.. list of directors \u0026 shareholdersWebMar 14, 2024 · Joshua T. Brumm has not been actively trading shares of Dyne Therapeutics during the last ninety days. Who are Dyne Therapeutics' active insiders? … image twirling bâtonWebDYN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Dyne Therapeutics Inc.. image twingo 1WebMarket Holidays Daily Analyst Ratings Daily Insider Trading. Research Tools . ... The Dyne Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a ... list of direct selling companiesWebDec 15, 2024 · The Trade: Dyne Therapeutics, Inc. DYN Director Jason Rhodes acquired a total of 934,581 shares at an average price of $10.70. To acquire these shares, it cost … image twint